Sartorius Group North America

Sartorius Group North America
Share

Sartorius Group North America

 •  September 28

Biopharma equipment supplier builds laboratory and office facility at Science Park III in Ulm, Germany Cell Culture Technology Center will cost around 30 million euros Goettingen/Ulm, Germany, September 28, 2017 – Sartorius Stedim Cellca is building a new 30-million-euro Cell Culture Technology Center at Science Park III in Eselsberg situated at...

Sartorius Group North America

 •  September 13

•New building covering approx. 25,000 square meters •The largest single investment of Sartorius Campus totaling around 42 million euros •Building protected by special construction against vibration Goettingen, Germany, September 13, 2017 – With its new facility for the manufacture of laboratory instruments, Sartorius provides high-quality...

Goettingen, Germany / Malmö, Sweden – June 26, 2017: Sartorius Stedim Biotech (SSB), a leading international supplier to the biopharmaceutical industry, has launched the Active Dashboard 2, an advanced software solution. Offered by its subsidiary, Sartorius Stedim Data Analytics, formerly known as Umetrics, the release features significant...

• Firms combine ambr® technology with the BioProfile® FLEX • Unique tool will allow massive quantities of cell culture data to be collected during upstream processing QbD studies Goettingen, GER – May 17, 2017: Sartorius Stedim Biotech (SSB), a leading international supplier to the biopharmaceutical industry, today announced an agreement with Nova...

Unique system offers collection of massive quantities of cell culture data QbD studies in upstream processing more rapidly performed On show for the first time at Cell Line Development & Engineering in San Diego Goettingen, Germany – June 5, 2017: Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry,...

Unique cell analysis platform for basic research and drug discovery has broad and expanding user base Acquisition to significantly enhance Sartorius’ Bioanalytics portfolio Goettingen, March 3, 2017 – Sartorius, a leading partner to the biopharmaceutical industry and laboratories, today signed an agreement to acquire U.S. based Essen BioScience...

With its unique portfolio, Sartorius Stedim Biotech supports mainstream adoption of QbD principles by the biopharmaceutical industry. Unique technology portfolio enables design space characterization, effective translation to the large-scale and enhanced process analytics Goettingen, Germany / Aubagne, France, January 18, 2017 – Sartorius Stedim...

Aubagne, July 6, 2016 – Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, today has signed a contract to acquire U.S. centrifuge specialist kSep Holdings, Inc. (kSep). The privately owned company based in Morrisville, North Carolina, has been operating on the market since 2011, and is expected to...

Goettingen, Germany | Boston, MA, USA – November 10, 2016: Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, opened a new bioanalytical and biosafety testing laboratory yesterday in the major biotech hub of Boston, Massachusetts. This dedicated bioanalytical laboratory is designed to accommodate...

Goettingen, April 20, 2016 - Sartorius, a leading international laboratory and pharmaceutical equipment supplier, got off to a successful start in fiscal 2016, with double-digit gains in sales revenue and earnings1. "We continue to see dynamic growth driven by both divisions and all business regions," commented CEO Dr. Joachim Kreuzburg....